Cargando…
MiR-23b-3p reduces the proliferation, migration and invasion of cervical cancer cell lines via the reduction of c-Met expression
Malignant transformation and progression in cancer is associated with the altered expression of multiple miRNAs, which are considered as post-transcriptional regulators of genes participating in various cellular processes. Although, it has been proposed that miR-23b-3p acts as a tumor suppressor in...
Autores principales: | Campos-Viguri, Gabriela Elizabeth, Peralta-Zaragoza, Oscar, Jiménez-Wences, Hilda, Longinos-González, Alma Edith, Castañón-Sánchez, Carlos Alberto, Ramírez-Carrillo, Miriam, Camarillo, César López, Castañeda-Saucedo, Eduardo, Jiménez-López, Marco Antonio, Martínez-Carrillo, Dinorah Nashely, Fernández-Tilapa, Gloria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7039958/ https://www.ncbi.nlm.nih.gov/pubmed/32094378 http://dx.doi.org/10.1038/s41598-020-60143-x |
Ejemplares similares
-
Human papilloma virus, DNA methylation and microRNA expression in cervical cancer (Review)
por: JIMÉNEZ-WENCES, HILDA, et al.
Publicado: (2014) -
miR-23b as a potential tumor suppressor and its regulation by DNA methylation in cervical cancer
por: Campos-Viguri, Gabriela Elizabeth, et al.
Publicado: (2015) -
Multiple infections by EBV, HCMV and Helicobacter pylori are highly frequent in patients with chronic gastritis and gastric cancer from Southwest Mexico: An observational study
por: Del Moral-Hernández, Oscar, et al.
Publicado: (2019) -
miR-23b-3p, miR-124-3p and miR-218-5p Synergistic or Additive Effects on Cellular Processes That Modulate Cervical Cancer Progression? A Molecular Balance That Needs Attention
por: Romero-López, Manuel Joaquín, et al.
Publicado: (2022) -
miR-218-5p/RUNX2 Axis Positively Regulates Proliferation and Is Associated with Poor Prognosis in Cervical Cancer
por: Cruz-De la Rosa, Merlin Itsel, et al.
Publicado: (2022)